Portfolio Thuja Capital Healthcare Fund II

Company: Salvia BioElectronics - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2018
Status: Active

Eindhoven based company developing a minimally invasive bioelectronics solution for people suffering from chronic neurological disease.

Company: CardiacBooster - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2018
Status: Active

Radboud UMC (Nijmegen) spin-off CardiacBooster develops a minimally invasive cardiac assist device indicated to temporarily support the heart through episodes of acute distress such as cariogenic shock or acute heart failure.

Company: Atro Medical - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2017
Status: Active

Nijmegen based Radboudumc spin-off Atro Medical develops an anatomically shaped polymer based meniscus implant, the Trammpolin, with the aim of restoring the protective function of the meniscus by acting as a joint spacer.

Company: NutriLeads - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2015
Status: Active

Wageningen based company active in the field of medical nutrition and functional foods. Currently develops a food ingredient with immune system enhancing properties to help combat infections.

Company: Encare Biotech - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2014
Status: Active

Encare Biotech is a spin-off of Utrecht UMC, dedicated to develop antibody therapeutics to prevent chronic heart failure as a consequence of a myocardial infarction.